Axon Enterprise Outpaces Stock Market Gains What You Should Know
| SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Slightly above 55% of Sio Gene's investors are presently thinking to get in. The analysis of current outlook of investing in Sio Gene Therapies suggests that some traders are interested regarding Sio Gene's prospects. Sio Gene's investing sentiment can be driven by a variety of factors including economic data, Sio Gene's earnings reports, geopolitical events, and overall market trends.
Sio |
Axon Enterprise closed at 198. in the latest trading session, marking a 1.51 percent move from the prior day.
Read at finance.yahoo.com
 |
Sio Gene Fundamental Analysis
We analyze Sio Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Sio Gene is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Sio Gene Therapies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sio Gene stock to make a market-neutral strategy. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics with similar companies.
Peers
Sio Gene Related Equities
| SRZN | Surrozen | 19.37 | ||||
| ALGS | Aligos Therapeutics | 10.96 | ||||
| MNPR | Monopar Therapeutics | 8.84 | ||||
| VINC | Vincerx Pharma | 7.69 | ||||
| CTMX | CytomX Therapeutics | 3.92 | ||||
| VCNX | Vaccinex | 2.44 | ||||
| ASMB | Assembly Biosciences | 1.25 | ||||
| RZLT | Rezolute | 1.00 | ||||
| XOMA | XOMA Corp | 0.84 | ||||
| NUVB | Nuvation Bio | 0.35 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| TARA | Protara Therapeutics | 0.99 | ||||
| SABS | SAB Biotherapeutics | 1.02 | ||||
| TPST | Tempest Therapeutics | 1.04 | ||||
| TIL | Instil Bio | 9.39 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |